Chief Executive Officer
Ludo Reynders’ title is Chief Executive Officer, but he describes his main role as Chief Customer Officer. He focuses on customer satisfaction, and especially on satisfying future rather than past market needs. “We have to focus on what we do best,” he says. “Things like supporting the exploding need for targeted therapies which requires the joint development of the diagnostic test and the therapeutic product. We are strong in both areas and we are ready to deploy our capabilities and align our services to our customers’ future needs.”
“We’re not a small copy of a big CRO. Our customers are relatively young and dynamic companies who know they will not be successful if they try to copy big pharma. They are open to new ways of doing things, and the opportunities are tremendous.”
Prior to joining Premier Research in October 2010, Ludo Reynders held a number of senior management positions in the CRO and pharmaceutical industries. As the CEO at AAIPharma, he led the reorganization of the company from a specialty pharmaceutical business to a full service development services company. As President of European operations and CEO of the CRO business at Quintiles, he was instrumental in the company’s international growth in Europe and then globally. At Bristol Myers, he was a key member of the team that developed the company’s European clinical development operations.
Dr. Reynders holds MS and PhD degrees in the applied biological sciences from the University of Leuven, Belgium.